U.S. markets closed

Akerna Corp. (KERN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.9900-0.1000 (-3.24%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close3.0900
Open3.0400
Bid2.9400 x 3200
Ask2.9900 x 800
Day's Range2.9400 - 3.0767
52 Week Range2.1700 - 10.4380
Volume567,455
Avg. Volume716,926
Market Cap80.141M
Beta (5Y Monthly)3.09
PE Ratio (TTM)N/A
EPS (TTM)-1.7200
Earnings DateAug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Akerna Corp.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more
  • Market Exclusive

    Weekly Roundup on the Cannabis Sector

    Key Takeaways: Akerna Corp. Acquires 365 Cannabis For $17M, Seeks To Create Most Comprehensive ERP System In Cannabis Industry. HEXO Corp. Achieves Carbon Neutrality. Fire & Flower Holdings Corp. Announces its Financial and Operational Results for the Fiscal Second Quarter Ended July 31, 2021. This was followed by Reports of Completed Acquisitions of PotGuide and […] The post Weekly Roundup on the Cannabis Sector appeared first on Market Exclusive.

  • Exec Edge

    Akerna CEO Jessica Billingsley Discusses Acquisition of 365 Cannabis

    By Jarrett Banks Akerna Corp (Nasdaq: KERN) has agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft Corp.’s Dynamics 365 Business Central, in a $17 million deal. Exec Edge sat down with Akerna CEO Jessica Billingsley to find out more. Exec Edge: Can you tell us about the acquisition and its […]

  • Benzinga

    20 Stocks Moving in Tuesday's Pre-Market Session

    Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ: DATS) rose 16.2% to $7.60 in pre-market trading after gaining around 4% on Monday. Akerna Corp. (NASDAQ: KERN) rose 11.5% to $3.69 in pre-market trading. The company agreed to acquire 365 Cannabis, a cannabis business management software system built on Microsoft's Dynamics 365 Business Central in a $17 million deal. Pa